论文标题
COVID-19测试的临床景观：艰难选择
Clinical Landscape of COVID-19 Testing: Difficult Choices
论文作者
论文摘要
2019年冠状病毒病（COVID-19）大流行在世界范围内迅速传播，导致大量的人类死亡和经济损失。在制定了确定的预防或治愈措施之前，有关测试，接触跟踪和隔离的政策仍然是遏制病毒传播的最佳公共卫生工具。测试是这些努力的关键组成部分，从而可以识别和隔离感染个体。测试方法，时间范围和结果的差异可能会影响其整体效率，可用性和功效。在此早期草案中，我们在各种类型的诊断测试中进行了比较，包括PCR，抗原和家庭测试与它们的相对优势，缺点和用例有关。我们还研究了替代性和非常规的方法。此外，我们分析了病毒的短期和长期影响及其对诸如商业，政府法律，政策和医疗保健等各种垂直领域的测试。
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the world, leading to enormous amounts of human death and economic loss. Until definitive preventive or curative measures are developed, policies regarding testing, contact tracing, and quarantine remain the best public health tools for curbing viral spread. Testing is a crucial component of these efforts, enabling the identification and isolation of infected individuals. Differences in testing methodologies, time frames, and outcomes can have an impact on their overall efficiency, usability and efficacy. In this early draft, we draw a comparison between the various types of diagnostic tests including PCR, antigen, and home tests in relation to their relative advantages, disadvantages, and use cases. We also look into alternative and unconventional methods. Further, we analyze the short-term and long-term impacts of the virus and its testing on various verticals such as business, government laws, policies, and healthcare.
